Could a cheap, old drug ease the struggle of heart failure?
NCT ID NCT06130059
Summary
This study is testing if a low dose of an anti-inflammatory drug called colchicine can help people with a specific type of chronic heart failure (HFpEF) who also have body-wide inflammation. For 3 months, 60 participants will take either the drug or a placebo pill to see if it improves how far they can walk, their exercise capacity, and their quality of life. The goal is to see if reducing inflammation can make daily physical activities easier for these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75235, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.